Log on / register
Feedback
|
Support
|
My details
home
|
journals A-Z
|
subject areas
|
advanced search
|
authors
|
reviewers
|
libraries
|
about
|
my BioMed Central
EGFR associated expression profiles vary with breast tumor subtype.
Hoadley KA, Weigman VJ, Fan C, Sawyer LR, He X, Troester MA, Sartor CI, Rieger-House T, Bernard PS, Carey LA, Perou CM
BMC Genomics
2007,
8
:258
[
Full text
]
[
PubMed
]
[
Related articles
]
[
Cited on BioMed Central
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 5 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
PubMed Central articles that cite the above article:
1.
In vitro and in vivo analysis of B-Myb in basal-like breast cancer.
Thorner AR, Hoadley KA, Parker JS, Winkel S, Millikan RC, Perou CM
Oncogene
2009 Feb 5,
28
:742-51
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
2.
Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer.
Di Leo A, Gomez HL, Aziz Z, Zvirbule Z, Bines J, Arbushites MC, Guerrera SF, Koehler M, Oliva C, Stein SH, Williams LS, Dering J, Finn RS, Press MF
J Clin Oncol
2008 Dec 1,
26
:5544-52
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
3.
Can systems biology understand pathway activation? Gene expression signatures as surrogate markers for understanding the complexity of pathway activation.
Itadani H, Mizuarai S, Kotani H
Curr Genomics
2008 Aug,
9
:349-60
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
4.
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
Dickler MN, Rugo HS, Eberle CA, Brogi E, Caravelli JF, Panageas KS, Boyd J, Yeh B, Lake DE, Dang CT, Gilewski TA, Bromberg JF, Seidman AD, D'Andrea GM, Moasser MM, Melisko M, Park JW, Dancey J, Norton L, Hudis CA
Clin Cancer Res
2008 Dec 1,
14
:7878-83
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
5.
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition.
Faber AC, Li D, Song Y, Liang MC, Yeap BY, Bronson RT, Lifshits E, Chen Z, Maira SM, García-Echeverría C, Wong KK, Engelman JA
Proc Natl Acad Sci U S A
2009 Nov 17,
106
:19503-8
[
PubMed Central
]
[
PubMed
]
[
Related articles
]
This article is also cited by
4 articles
in BioMed Central
You can also
check ISI Web of Science
for additional citations (subscription required)
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
all 5 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.